Routine screening for CYP2C19 polymorphisms for patients being treated with clopidogrel is not recommended

Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health

Volumn 74, Issue 1, 2015, Pages 16-20

  Bhopalwala, Adnan M ^a   Hong, Robert A ^a   Khan, Zia R ^a   Valentin, Mona R ^a   Badawi, Ramy A ^a  

^a QUEEN S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; CYTOCHROME P450 2C19; TICLOPIDINE;

ANALOGS AND DERIVATIVES; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETICS; HAWAII; HUMAN; MASS SCREENING; PROCEDURES;

CYTOCHROME P-450 CYP2C19; GENETIC TESTING; HAWAII; HUMANS; MASS SCREENING; POLYMORPHISM, GENETIC; TICLOPIDINE;

EID: 85016520625     PISSN: None     EISSN: 21658242     Source Type: Journal    
DOI: None     Document Type: Article

References (0)